Scarica l'app Stockscreener
3.17
0.35%
0.00
Precedente Chiudi:
$3.17
Aprire:
$3.14
Volume 24 ore:
41,392
Relative Volume:
0.05
Capitalizzazione di mercato:
$356.62M
Reddito:
$69.56M
Utile/perdita netta:
$-240.05M
Rapporto P/E:
-1.0746
EPS:
-2.95
Flusso di cassa netto:
$-121.90M
1 W Prestazione:
+2.28%
1M Prestazione:
-3.02%
6M Prestazione:
+101.33%
1 anno Prestazione:
+3.95%
Intervallo 1D:
$3.14
$3.19
Intervallo di 1 settimana:
$3.035
$3.235
Portata 52W:
$1.05
$3.97
Adc Therapeutics Sa Stock (ADCT) Company Profile
Nome
Adc Therapeutics Sa
Settore
Industria
Telefono
41 21 653 02 00
Indirizzo
BIOPOLE, EPALINGES
Confronta ADCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
3.17 | 347.62M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.86 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
595.39 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.41 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
705.55 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.75 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-08 | Iniziato | Stephens | Overweight |
| 2024-05-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-28 | Iniziato | Guggenheim | Buy |
| 2023-08-10 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-12-06 | Iniziato | CapitalOne | Overweight |
| 2022-11-09 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-09-21 | Iniziato | JP Morgan | Overweight |
| 2022-09-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | Iniziato | Wolfe Research | Outperform |
| 2021-08-17 | Ripresa | Jefferies | Buy |
| 2021-08-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-12-03 | Iniziato | Stifel | Hold |
| 2020-10-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-06-09 | Iniziato | BofA/Merrill | Buy |
| 2020-06-09 | Iniziato | Cowen | Outperform |
Mostra tutto
Adc Therapeutics Sa Borsa (ADCT) Ultime notizie
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025 - PR Newswire
What MACD and RSI say about ADC Therapeutics SAJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - Newser
Is ADC Therapeutics SA stock ready for a breakoutTrade Exit Summary & AI Powered Buy/Sell Recommendations - Newser
Using data tools to time your ADC Therapeutics SA exitPortfolio Return Report & Smart Money Movement Alerts - Newser
Real time pattern detection on ADC Therapeutics SA stock2025 Short Interest & Community Consensus Picks - Newser
What’s next for ADC Therapeutics SA stock priceJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - Newser
What recovery options are there for ADC Therapeutics SA2025 Pullback Review & Risk Controlled Daily Plans - Newser
ADC Therapeutics SA stock trend outlook and recovery pathJuly 2025 Review & Weekly High Potential Stock Alerts - Newser
Can momentum traders help lift ADC Therapeutics SAJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser
Can ADC Therapeutics SA hit a new high this monthDollar Strength & Fast Moving Stock Trade Plans - Newser
Analyzing drawdowns of ADC Therapeutics SA with statistical toolsBond Market & Short-Term Trading Opportunity Alerts - Newser
What high frequency data says about ADC Therapeutics SAJuly 2025 Summary & Precise Swing Trade Entry Alerts - Newser
Backtesting results for ADC Therapeutics SA trading strategiesTrade Ideas & Intraday High Probability Setup Alerts - Newser
How to escape a deep drawdown in ADC Therapeutics SADay Trade & Community Consensus Trade Alerts - Newser
ADC Therapeutics SA stock prediction for this weekWeekly Trend Summary & Community Supported Trade Ideas - Newser
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - ADVFN Brasil
Reversal indicators forming on ADC Therapeutics SA stockWeekly Trade Review & Real-Time Stock Movement Alerts - Newser
Identifying reversal signals in ADC Therapeutics SA2025 Breakouts & Breakdowns & Technical Confirmation Alerts - Newser
Should you hold or exit ADC Therapeutics SA nowPortfolio Risk Report & Weekly Watchlist of Top Performers - Newser
Will ADC Therapeutics SA stock go up soonCEO Change & AI Forecasted Entry/Exit Points - Newser
Will ADC Therapeutics SA continue its uptrendWall Street Watch & Fast Gaining Stock Strategy Reports - Newser
Is ADC Therapeutics SA part of any major index2025 Earnings Impact & Real-Time Chart Pattern Alerts - theviewers.co.kr
ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update - ADVFN Brasil
What’s the outlook for ADC Therapeutics SA’s sectorJuly 2025 Levels & Free Technical Pattern Based Buy Signals - theviewers.co.kr
What makes ADC Therapeutics SA stock price move sharplyGap Up & Community Consensus Stock Picks - Newser
ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025 - Quantisnow
ADC Therapeutics to Host First Quarter 2025 Financial Results Conference Call on May 14, 2025 - Quantisnow
Technical Models Detect Momentum Build in ADC Therapeutics SA2025 Market WrapUp & Weekly High Conviction Ideas - 더경남뉴스
Valuation Update: What’s the outlook for ADC Therapeutics SA’s sectorJuly 2025 Chart Watch & Real-Time Buy Signal Alerts - baoquankhu1.vn
ADC Therapeutics SA Approaches Psychological Resistance Level2025 Valuation Update & AI Powered Trade Plan Recommendations - 더경남뉴스
ADC Therapeutics (NYSE:ADCT) Cut to Sell at Wall Street Zen - MarketBeat
Brokerages Set ADC Therapeutics SA (NYSE:ADCT) Target Price at $7.75 - MarketBeat
FY2025 EPS Estimate for ADC Therapeutics Boosted by Analyst - MarketBeat
What candlestick patterns are forming on ADC Therapeutics SALong Setup & Real-Time Volume Spike Alerts - Newser
ADC Therapeutics SA Price Holds Above Key Fib LevelQuarterly Risk Review & Precise Trade Entry Recommendations - newsyoung.net
Guggenheim Reiterates Buy Rating for ADC Therapeutics (NYSE:ADCT) - MarketBeat
Multi factor analysis applied to ADC Therapeutics SAQuarterly Profit Summary & Short-Term Trading Alerts - Newser
RSI + MACD Show Convergence for ADC Therapeutics SAPortfolio Return Report & Free Weekly Chart Analysis and Trade Guides - newsyoung.net
How to integrate ADC Therapeutics SA into portfolio analysis toolsJuly 2025 Highlights & Risk Controlled Stock Alerts - Newser
Using data models to predict ADC Therapeutics SA stock movement2025 Trading Volume Trends & Stock Timing and Entry Methods - Newser
ADC Therapeutics (NYSE:ADCT) Issues Quarterly Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Is ADC Therapeutics SA the Top Chart Pick This WeekMarket Volume Summary & Free Weekly Watchlist of Top Performers - beatles.ru
Is It Too Late to Sell ADC Therapeutics SAWeekly Stock Report & Low Drawdown Momentum Trade Ideas - beatles.ru
Real Time Data Flags Unusual Activity in ADC Therapeutics SAJuly 2025 Fed Impact & High Conviction Buy Zone Picks - metal.it
ADC Therapeutics Reports Q2 2025 Financial Results: Earnings Breakdown and Strategic Maneuvers - AInvest
ADC Therapeutics S.A. (NYSE:ADCT) Q2 2025 Earnings Call Transcript - Insider Monkey
ADC Therapeutics 2025 Q2 Earnings Deeper Losses Amid Revenue Growth - AInvest
Adc Therapeutics Sa Azioni (ADCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.46%
6.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):